Nanoformulated copper/zinc superoxide dismutase attenuates vascular cell activation and aortic inflammation in obesity

Saraswathi Viswanathan, Murali Ganesan, Curtis Perriotte-Olson, Devika S. Manickam, Rachel A. Westwood, Matthew C Zimmerman, Iman M Ahmad, Cyrus V Desouza, Alexander V. Kabanov

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective Endothelial cell (EC) oxidative stress can lead to vascular dysfunction which is an underlying event in the development of cardiovascular disease (CVD). The lack of a potent and bioavailable anti-oxidant enzyme is a major challenge in studies on antioxidant therapy. The objective of this study is to determine whether copper/zinc superoxide dismutase (CuZnSOD or SOD1) after nanoformulation (nanoSOD) can effectively reduce EC oxidative stress and/or vascular inflammation in obesity. Methods. Human aortic endothelial cells (HAECs) were treated with native- or nanoSOD for 6 h followed by treatment with linoleic acid (LA), a free fatty acid, for 6-24 h. To determine the in vivo relevance, the effectiveness of nanoSOD in reducing vascular cell activation was studied in a mouse model of diet-induced obesity. Results. We noted that nanoSOD was more effectively taken up by ECs than native SOD. Western blot analysis further confirmed that the intracellular accumulation of SOD1 protein was greatly increased upon nanoSOD treatment. Importantly, nanoSOD pretreatment led to a significant decrease in LA-induced oxidative stress in ECs which was associated with a marked increase in SOD enzyme activity in ECs. In vivo studies showed a significant decrease in markers of EC/vascular cell activation and/or inflammation in visceral adipose tissue (VAT), thoracic aorta, and heart collected from nanoSOD-treated mice compared to obese control mice. Interestingly, the expression of metallothionein 2, an antioxidant gene was significantly increased in nanoSOD-treated mice. Conclusion. Our data show that nanoSOD is very effective in delivering active SOD to ECs and in reducing EC oxidative stress. Our data also demonstrate that nanoSOD will be a useful tool to reduce vascular cell activation in VAT and aorta in obesity which, in turn, can protect against obesity-associated CVD, in particular, hypertension.

Original languageEnglish (US)
Pages (from-to)495-500
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume469
Issue number3
DOIs
StatePublished - Jan 15 2016

Fingerprint

Endothelial cells
Oxidative stress
Superoxide Dismutase
Blood Vessels
Zinc
Copper
Endothelial Cells
Obesity
Chemical activation
Inflammation
Oxidative Stress
Intra-Abdominal Fat
Linoleic Acid
Cardiovascular Diseases
Antioxidants
Far-Western Blotting
Tissue
Obese Mice
Metallothionein
Enzyme activity

Keywords

  • Free fatty acid
  • NanoSOD
  • Obesity
  • Oxidative stress
  • Superoxide dismutase
  • Vascular inflammation

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Nanoformulated copper/zinc superoxide dismutase attenuates vascular cell activation and aortic inflammation in obesity. / Viswanathan, Saraswathi; Ganesan, Murali; Perriotte-Olson, Curtis; Manickam, Devika S.; Westwood, Rachel A.; Zimmerman, Matthew C; Ahmad, Iman M; Desouza, Cyrus V; Kabanov, Alexander V.

In: Biochemical and Biophysical Research Communications, Vol. 469, No. 3, 15.01.2016, p. 495-500.

Research output: Contribution to journalArticle

@article{ad4344b9a001418f8bdf3abf9ae25e83,
title = "Nanoformulated copper/zinc superoxide dismutase attenuates vascular cell activation and aortic inflammation in obesity",
abstract = "Objective Endothelial cell (EC) oxidative stress can lead to vascular dysfunction which is an underlying event in the development of cardiovascular disease (CVD). The lack of a potent and bioavailable anti-oxidant enzyme is a major challenge in studies on antioxidant therapy. The objective of this study is to determine whether copper/zinc superoxide dismutase (CuZnSOD or SOD1) after nanoformulation (nanoSOD) can effectively reduce EC oxidative stress and/or vascular inflammation in obesity. Methods. Human aortic endothelial cells (HAECs) were treated with native- or nanoSOD for 6 h followed by treatment with linoleic acid (LA), a free fatty acid, for 6-24 h. To determine the in vivo relevance, the effectiveness of nanoSOD in reducing vascular cell activation was studied in a mouse model of diet-induced obesity. Results. We noted that nanoSOD was more effectively taken up by ECs than native SOD. Western blot analysis further confirmed that the intracellular accumulation of SOD1 protein was greatly increased upon nanoSOD treatment. Importantly, nanoSOD pretreatment led to a significant decrease in LA-induced oxidative stress in ECs which was associated with a marked increase in SOD enzyme activity in ECs. In vivo studies showed a significant decrease in markers of EC/vascular cell activation and/or inflammation in visceral adipose tissue (VAT), thoracic aorta, and heart collected from nanoSOD-treated mice compared to obese control mice. Interestingly, the expression of metallothionein 2, an antioxidant gene was significantly increased in nanoSOD-treated mice. Conclusion. Our data show that nanoSOD is very effective in delivering active SOD to ECs and in reducing EC oxidative stress. Our data also demonstrate that nanoSOD will be a useful tool to reduce vascular cell activation in VAT and aorta in obesity which, in turn, can protect against obesity-associated CVD, in particular, hypertension.",
keywords = "Free fatty acid, NanoSOD, Obesity, Oxidative stress, Superoxide dismutase, Vascular inflammation",
author = "Saraswathi Viswanathan and Murali Ganesan and Curtis Perriotte-Olson and Manickam, {Devika S.} and Westwood, {Rachel A.} and Zimmerman, {Matthew C} and Ahmad, {Iman M} and Desouza, {Cyrus V} and Kabanov, {Alexander V.}",
year = "2016",
month = "1",
day = "15",
doi = "10.1016/j.bbrc.2015.12.027",
language = "English (US)",
volume = "469",
pages = "495--500",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Nanoformulated copper/zinc superoxide dismutase attenuates vascular cell activation and aortic inflammation in obesity

AU - Viswanathan, Saraswathi

AU - Ganesan, Murali

AU - Perriotte-Olson, Curtis

AU - Manickam, Devika S.

AU - Westwood, Rachel A.

AU - Zimmerman, Matthew C

AU - Ahmad, Iman M

AU - Desouza, Cyrus V

AU - Kabanov, Alexander V.

PY - 2016/1/15

Y1 - 2016/1/15

N2 - Objective Endothelial cell (EC) oxidative stress can lead to vascular dysfunction which is an underlying event in the development of cardiovascular disease (CVD). The lack of a potent and bioavailable anti-oxidant enzyme is a major challenge in studies on antioxidant therapy. The objective of this study is to determine whether copper/zinc superoxide dismutase (CuZnSOD or SOD1) after nanoformulation (nanoSOD) can effectively reduce EC oxidative stress and/or vascular inflammation in obesity. Methods. Human aortic endothelial cells (HAECs) were treated with native- or nanoSOD for 6 h followed by treatment with linoleic acid (LA), a free fatty acid, for 6-24 h. To determine the in vivo relevance, the effectiveness of nanoSOD in reducing vascular cell activation was studied in a mouse model of diet-induced obesity. Results. We noted that nanoSOD was more effectively taken up by ECs than native SOD. Western blot analysis further confirmed that the intracellular accumulation of SOD1 protein was greatly increased upon nanoSOD treatment. Importantly, nanoSOD pretreatment led to a significant decrease in LA-induced oxidative stress in ECs which was associated with a marked increase in SOD enzyme activity in ECs. In vivo studies showed a significant decrease in markers of EC/vascular cell activation and/or inflammation in visceral adipose tissue (VAT), thoracic aorta, and heart collected from nanoSOD-treated mice compared to obese control mice. Interestingly, the expression of metallothionein 2, an antioxidant gene was significantly increased in nanoSOD-treated mice. Conclusion. Our data show that nanoSOD is very effective in delivering active SOD to ECs and in reducing EC oxidative stress. Our data also demonstrate that nanoSOD will be a useful tool to reduce vascular cell activation in VAT and aorta in obesity which, in turn, can protect against obesity-associated CVD, in particular, hypertension.

AB - Objective Endothelial cell (EC) oxidative stress can lead to vascular dysfunction which is an underlying event in the development of cardiovascular disease (CVD). The lack of a potent and bioavailable anti-oxidant enzyme is a major challenge in studies on antioxidant therapy. The objective of this study is to determine whether copper/zinc superoxide dismutase (CuZnSOD or SOD1) after nanoformulation (nanoSOD) can effectively reduce EC oxidative stress and/or vascular inflammation in obesity. Methods. Human aortic endothelial cells (HAECs) were treated with native- or nanoSOD for 6 h followed by treatment with linoleic acid (LA), a free fatty acid, for 6-24 h. To determine the in vivo relevance, the effectiveness of nanoSOD in reducing vascular cell activation was studied in a mouse model of diet-induced obesity. Results. We noted that nanoSOD was more effectively taken up by ECs than native SOD. Western blot analysis further confirmed that the intracellular accumulation of SOD1 protein was greatly increased upon nanoSOD treatment. Importantly, nanoSOD pretreatment led to a significant decrease in LA-induced oxidative stress in ECs which was associated with a marked increase in SOD enzyme activity in ECs. In vivo studies showed a significant decrease in markers of EC/vascular cell activation and/or inflammation in visceral adipose tissue (VAT), thoracic aorta, and heart collected from nanoSOD-treated mice compared to obese control mice. Interestingly, the expression of metallothionein 2, an antioxidant gene was significantly increased in nanoSOD-treated mice. Conclusion. Our data show that nanoSOD is very effective in delivering active SOD to ECs and in reducing EC oxidative stress. Our data also demonstrate that nanoSOD will be a useful tool to reduce vascular cell activation in VAT and aorta in obesity which, in turn, can protect against obesity-associated CVD, in particular, hypertension.

KW - Free fatty acid

KW - NanoSOD

KW - Obesity

KW - Oxidative stress

KW - Superoxide dismutase

KW - Vascular inflammation

UR - http://www.scopus.com/inward/record.url?scp=84953410365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84953410365&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2015.12.027

DO - 10.1016/j.bbrc.2015.12.027

M3 - Article

C2 - 26692492

AN - SCOPUS:84953410365

VL - 469

SP - 495

EP - 500

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 3

ER -